About Salve Therapeutics
Salve Therapeutics is a private company based in San Pedro, California, incorporated in 2022 in Delaware. It has reported $12,500 raised in one offering on Form D since May 2025. Its chief executive is Stefan Lukianov.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 10, 2024 | May 2, 2025 | $12,500of $687K target | 3 | $4,167 | EquityRule 506(c) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Salve Therapeutics's Form D filed May 2, 2025.
SL